Todays news this morning confirms that the NDT Pharmaceutical Inc / $MILV R/M is a done deal, and will no longer be a shell under custodian rule closing the deal.
What does that mean?
It means the JV ownership of years of research at UPennMed on TBI-Traumatic Brain Injury repair BBB-Blood Brain Barrier crossing Liposome tech ASSETS are now part of the MILV assets.
It has major game changer Biotech-Pharma assets now and is no longer a shell, and has no share dumps and or debt to service, or existing revenue to free fall like Cruise lines and airlines and Boeing do.
It may have some early products they will introduce in weeks or days that help the body fight #COVID19 infections to limit damage to organs per the VEP-Lipsome Tech disclosed my the NDT Pharma folks R/M with $MILV, in 2016 SEC fillings.
The Now $MILV/NDT Pharma VEP-Liposome tech specifically mentioned protecting organs from cell damage......
No small thing sir.
Yes this is a good thing, LOL
News 
Market Data 
Discover 
